Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arginine vasopressin receptor 2 activation promotes microvascular permeability in sepsis. | Pharmacol Res | 2021 | 33160069 | PubTator, text mining | PubMed |
| Thiazide diuretics and the rate of disease progression in autosomal dominant polycystic kidney disease: an observational study. | Nephrol Dial Transplant | 2021 | 33150452 | PubTator, text mining | PubMed |
| A Functional Hexaphenylbenzene Library Comprising of One, Three, and Six Peripheral Rylene-Diimide Substituents. | Chemistry | 2021 | 33140885 | PubTator, text mining | PubMed |
| A patient with congenital nephrogenic diabetes insipidus due to AVPR2 mutation complicated by persisting polydipsia under hemodialysis treatment. | CEN Case Rep | 2021 | 33125666 | PubTator, text mining | PubMed |
| A method for identifying G protein-coupled receptor dimers and their interfaces. | Biochim Biophys Acta Mol Cell Res | 2021 | 33075383 | PubTator, text mining | PubMed |
| Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study. | Curr Vasc Pharmacol | 2021 | 32957887 | PubTator, text mining | PubMed |
| Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases. | Biochim Biophys Acta Mol Basis Dis | 2021 | 32949766 | PubTator, text mining | PubMed |
| Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. | Eur J Heart Fail | 2021 | 32946151 | PubTator, text mining | PubMed |
| Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial. | Nephrol Dial Transplant | 2021 | 32901255 | PubTator, text mining | PubMed |
A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial. | Int Braz J Urol | 2021 | 32840337 | PubTator, text mining | PubMed |
| Vasopressor Therapy in the Intensive Care Unit. | Semin Respir Crit Care Med | 2021 | 32820475 | PubTator, text mining | PubMed |
| Quantitative Systems Toxicology Modeling Predicts that Reduced Biliary Efflux Contributes to Tolvaptan Hepatotoxicity. | Clin Pharmacol Ther | 2021 | 32748396 | PubTator, text mining | PubMed |
| Hydration for health hypothesis: a narrative review of supporting evidence. | Eur J Nutr | 2021 | 32632658 | PubTator, text mining | PubMed |
| Phosphoproteomic Identification of Vasopressin/cAMP/Protein Kinase A-Dependent Signaling in Kidney. | Mol Pharmacol | 2021 | 32245905 | PubTator, text mining | PubMed |
| Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men. | Neuroendocrinology | 2021 | 32074621 | PubTator, text mining | PubMed |
| In vivo diffusion-weighted MRS using semi-LASER in the human brain at 3 T: Methodological aspects and clinical feasibility. | NMR Biomed | 2021 | 31930768 | PubTator, text mining | PubMed |
| Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases. | Nephrol Dial Transplant | 2021 | 31738409 | PubTator, text mining | PubMed |
| Management of Acute Heart Failure during an Early Phase. | Int J Heart Fail | 2020 | 36263292 | PubTator, text mining | PubMed |
| Regiocontrolled dimerization of asymmetric diazaheptacene derivatives toward X-shaped porous semiconductors. | Chem Sci | 2020 | 34094364 | PubTator, text mining | PubMed |
| Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer. | Front Cell Dev Biol | 2020 | 33520985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=45